CHRS logo

Coherus BioSciences (CHRS) Debt To Equity Ratio

Annual Debt To Equity

-2.45
+0.98+28.57%

December 31, 2023


Summary


Performance

CHRS Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCHRSfinancial healthmetrics:

Quarterly Debt To Equity

-3.01
+0.13+4.14%

September 30, 2024


Summary


Performance

CHRS Quarterly Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCHRSfinancial healthmetrics:

Debt To Equity Formula

Debt To Equity =  
Total Debt
Shareholders Equity

CHRS Debt To Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+28.6%+15.0%
3 y3 years-270.1%-11.5%
5 y5 years+8.2%-11.5%

CHRS Debt To Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-158.6%+28.6%-109.0%+83.8%
5 y5-year-158.6%+28.6%-109.0%+83.8%
alltimeall time-150.2%+28.6%-109.0%+94.7%

Coherus BioSciences Debt To Equity History

DateAnnualQuarterly
Sep 2024
-
-3.01(-4.1%)
Jun 2024
-
-3.14(-45.9%)
Mar 2024
-
-5.80(+136.7%)
Dec 2023
-2.45(-28.6%)
-2.45(-30.8%)
Sep 2023
-
-3.54(+31.1%)
Jun 2023
-
-2.70(+12.5%)
Mar 2023
-
-2.40(-30.0%)
Dec 2022
-3.43(-182.1%)
-3.43(-29.1%)
Sep 2022
-
-4.84(-74.0%)
Jun 2022
-
-18.60(-155.6%)
Mar 2022
-
33.47(+700.7%)
Dec 2021
4.18(+190.3%)
4.18(+34.4%)
Sep 2021
-
3.11(+19.6%)
Jun 2021
-
2.60(-18.0%)
Mar 2021
-
3.17(+120.1%)
Dec 2020
1.44(-15.3%)
1.44(-8.9%)
Sep 2020
-
1.58(-16.0%)
Jun 2020
-
1.88(+64.9%)
Mar 2020
-
1.14(-32.9%)
Dec 2019
1.70
1.70(-46.4%)
Sep 2019
-
3.17(-107.1%)
Jun 2019
-
-44.46(+868.6%)
DateAnnualQuarterly
Mar 2019
-
-4.59(+71.9%)
Dec 2018
-2.67(-183.7%)
-2.67(-132.2%)
Sep 2018
-
8.29(+411.7%)
Jun 2018
-
1.62(-102.9%)
Mar 2018
-
-56.84(-1881.8%)
Dec 2017
3.19(-34.6%)
3.19(+77.2%)
Sep 2017
-
1.80(-42.7%)
Jun 2017
-
3.14(+143.4%)
Mar 2017
-
1.29(-73.6%)
Dec 2016
4.88(>+9900.0%)
4.88(+60.5%)
Sep 2016
-
3.04(-285.4%)
Jun 2016
-
-1.64(+9.3%)
Mar 2016
-
-1.50(<-9900.0%)
Dec 2015
0.00(0.0%)
0.00(0.0%)
Sep 2015
-
0.00(0.0%)
Jun 2015
-
0.00(0.0%)
Mar 2015
-
0.00(0.0%)
Dec 2014
0.00(-100.0%)
0.00(0.0%)
Sep 2014
-
0.00(0.0%)
Jun 2014
-
0.00(-100.0%)
Dec 2013
-0.10(<-9900.0%)
-0.10
Dec 2012
0.00
-

FAQ

  • What is Coherus BioSciences annual debt to equity ratio?
  • What is the all time high annual debt to equity for Coherus BioSciences?
  • What is Coherus BioSciences annual debt to equity year-on-year change?
  • What is Coherus BioSciences quarterly debt to equity ratio?
  • What is the all time high quarterly debt to equity for Coherus BioSciences?
  • What is Coherus BioSciences quarterly debt to equity year-on-year change?

What is Coherus BioSciences annual debt to equity ratio?

The current annual debt to equity of CHRS is -2.45

What is the all time high annual debt to equity for Coherus BioSciences?

Coherus BioSciences all-time high annual debt to equity ratio is 4.88

What is Coherus BioSciences annual debt to equity year-on-year change?

Over the past year, CHRS annual debt to equity ratio has changed by +0.98 (+28.57%)

What is Coherus BioSciences quarterly debt to equity ratio?

The current quarterly debt to equity of CHRS is -3.01

What is the all time high quarterly debt to equity for Coherus BioSciences?

Coherus BioSciences all-time high quarterly debt to equity ratio is 33.47

What is Coherus BioSciences quarterly debt to equity year-on-year change?

Over the past year, CHRS quarterly debt to equity ratio has changed by +0.53 (+14.97%)